Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1
暂无分享,去创建一个
M. Freeman | V. Nizet | S. Akira | T. Mayadas | D. Kasper | O. Takeuchi | D. Golenbock | R. Malley | E. Lien | R. Ingalls | P. Henneke
[1] V. Nizet,et al. Novel Engagement of CD14 and Multiple Toll-Like Receptors by Group B Streptococci1 , 2001, The Journal of Immunology.
[2] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[3] Dirk E. Smith,et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.
[4] R. Medzhitov,et al. TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.
[5] M. Abreu,et al. Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.
[6] U. Göbel,et al. Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-κB Translocation* , 2001, The Journal of Biological Chemistry.
[7] D. Golenbock,et al. Extolling the diversity of bacterial endotoxins , 2001, Nature Immunology.
[8] S. Akira,et al. CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.
[9] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.
[10] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[11] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[12] L. Tong,et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.
[13] K. Moore,et al. Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages1 , 2000, The Journal of Immunology.
[14] H. Petty,et al. Cutting Edge: Lipopolysaccharide Induces Physical Proximity Between CD14 and Toll-Like Receptor 4 (TLR4) Prior to Nuclear Translocation of NF-κB1 , 2000, The Journal of Immunology.
[15] M. Netea,et al. Interleukin‐18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin‐1β , 2000, European journal of immunology.
[16] S. Akira,et al. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88 , 2000, Current Biology.
[17] G. Mancuso,et al. β2 Integrins Are Involved in Cytokine Responses to Whole Gram-Positive Bacteria1 , 2000, The Journal of Immunology.
[18] D. Golenbock,et al. Human Toll-Like Receptor 2 Mediates Monocyte Activation by Listeria monocytogenes, But Not by Group B Streptococci or Lipopolysaccharide1 , 2000, The Journal of Immunology.
[19] G. Mancuso,et al. Human Monocyte Receptors Involved in Tumor Necrosis Factor Responses to Group B Streptococcal Products , 2000, Infection and Immunity.
[20] S. Akira,et al. Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.
[21] H. Petty,et al. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. , 2000, Journal of immunology.
[22] A. Aderem,et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.
[23] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[24] B. Bloom,et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.
[25] A. Gurney,et al. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. , 1999, Journal of immunology.
[26] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[27] D. Golenbock,et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.
[28] M. Rothe,et al. Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.
[29] T. Mayadas,et al. Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression. , 1999, Journal of immunology.
[30] B. Monks,et al. Membrane Expression of Soluble Endotoxin-binding Proteins Permits Lipopolysaccharide Signaling in Chinese Hamster Ovary Fibroblasts Independently of CD14* , 1999, The Journal of Biological Chemistry.
[31] F. Gusovsky,et al. Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.
[32] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[33] L. Larivière,et al. Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.
[34] A. Schuchat. Group B streptococcus , 1999, The Lancet.
[35] A. Aderem,et al. Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.
[36] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[37] B. Monks,et al. CD11/CD18 and CD14 share a common lipid A signaling pathway. , 1998, Journal of immunology.
[38] D. Golenbock,et al. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. , 1998, Journal of immunology.
[39] D. Golenbock,et al. LPS‐binding proteins and receptors , 1998, Journal of leukocyte biology.
[40] D. Golenbock,et al. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. , 1998, Journal of immunology.
[41] M. Arnaout,et al. Outside-in signaling by lipopolysaccharide through a tailless integrin. , 1997, Journal of immunology.
[42] H. Flad,et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.
[43] S Askari,et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. , 1996, Immunity.
[44] J. Vallejo,et al. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci , 1996, Infection and immunity.
[45] L. Paoletti,et al. Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide , 1996, Infection and immunity.
[46] D. Kasper,et al. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. , 1996, The Journal of infectious diseases.
[47] S. Pillai,et al. Innate immunity. , 1996, Current opinion in immunology.
[48] R. van Furth,et al. Antimicrobial functions of mononuclear phagocytes. , 1994, Journal of immunological methods.
[49] R. Thieringer,et al. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. , 1994, The Journal of biological chemistry.
[50] L. McCormick,et al. Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent , 1994, Infection and immunity.
[51] C. Nathan,et al. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.
[52] M. Leinonen,et al. Epidemiology of invasive pneumococcal infections in children in Finland. , 1992, JAMA.
[53] D. Kasper,et al. Neonatal mouse model of group B streptococcal infection. , 1992, The Journal of infectious diseases.
[54] M. Sherman,et al. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody. , 1992, The American review of respiratory disease.
[55] M. Wessels,et al. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci , 1992, Infection and immunity.
[56] E. Chi,et al. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. , 1992, The Journal of infectious diseases.
[57] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[58] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[59] S. Goyert,et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.
[60] J. Kearney,et al. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae , 1984, The Journal of experimental medicine.
[61] S. Sahlin,et al. Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. , 1983, Journal of immunological methods.
[62] L. McCormick,et al. Streptococcus-Induced Nitric Oxide Production in Murine Macrophages Is CR 3 ( CD 11 b / CD 18 ) Dependent , 2022 .